Fatebenefratelli Hospital is a hospital located on the western side of the Tiber Island in Rome. It was established in 1585 and is currently run by the Brothers Hospitallers of Saint John of God.

During the past decade, Ospedale S. Giovanni Calibita Fatebenefratelli conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale S. Giovanni Calibita Fatebenefratelli" #1 sponsor was "National Cancer Institute, Naples" with 12 trials, followed by "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 7 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "Fadoi Foundation, Italy" with 3 trials sponsored and "Gruppo Oncologico del Nord-Ovest" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale S. Giovanni Calibita Fatebenefratelli" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 6 trials as a collaborator, "Azienda Ospedaliero, Universitaria Ospedali Riuniti" with 1 trials as a collaborator, "Bracco Corporate" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cattedra di Endocrinochirurgia, Università di Verona" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale S. Giovanni Calibita Fatebenefratelli" are "Metastatic Colorectal Cancer" (5 trials), "Ovarian Cancer" (5 trials), "Atrial Fibrillation" (2 trials), "Endometrial Cancer" (2 trials) and "Hospitalization" (2 trials). Many other conditions were trialed in "Ospedale S. Giovanni Calibita Fatebenefratelli" in a lesser frequency.

Most popular intervention types in "Ospedale S. Giovanni Calibita Fatebenefratelli" are "Drug" (31 trials), "Other" (4 trials), "Device" (3 trials), "Procedure" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (4 trials), "Paclitaxel" (4 trials), "Placebo" (4 trials), "carboplatin" (4 trials) and "Bevacizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale S. Giovanni Calibita Fatebenefratelli" are 31 trials for "All" genders and 11 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale S. Giovanni Calibita Fatebenefratelli". undefined are not yet recruiting, 4 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Ospedale S. Giovanni Calibita Fatebenefratelli, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale S. Giovanni Calibita Fatebenefratelli, 1 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".

Ospedale S. Giovanni Calibita Fatebenefratelli has several departments that took part in Clinical trials: "Ospedale San Giovanni Calibita Fatebenefratell;Neurologia" - 8 trials, "Ospedale S. Giovanni Calibita Fatebenefratelli, UO di Oncologia" - 4 trials, "Ospedale Fatebenefratelli, U.O.C. Cardiologia" - 3 trials, "Ospedale S.G.Calibita Fatebenefratelli; Unità Operativa Oncologia" - 2 trials